154 related articles for article (PubMed ID: 3206137)
1. [Treatment of myasthenia].
Fève JR
Rev Prat; 1988 Oct; 38(22):1541-5. PubMed ID: 3206137
[No Abstract] [Full Text] [Related]
2. [Therapy of myasthenia gravis].
Jerusalem F
Dtsch Med Wochenschr; 1977 Aug; 102(32):1160-3. PubMed ID: 196820
[No Abstract] [Full Text] [Related]
3. [Current therapy of myasthenia].
Zumstein V; Regli F
Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
[No Abstract] [Full Text] [Related]
4. Management of myasthenia gravis.
Schwendimann RN; Burton E; Minagar A
Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic considerations in myasthenia gravis].
Vejvalka J
Cesk Neurol Neurochir; 1984 Mar; 47(2):78-84. PubMed ID: 6705094
[No Abstract] [Full Text] [Related]
6. [Treatment of myasthenia gravis--pathophysiological evaluation of various forms of treatment and practical aspects of therapy (author's transl)].
Ito N
No To Shinkei; 1980 Sep; 32(9):921-9. PubMed ID: 7437165
[No Abstract] [Full Text] [Related]
7. [Therapies of myasthenia gravis (author's transl)].
de Crousaz G
Schweiz Rundsch Med Prax; 1978 Jan; 67(4):113-7. PubMed ID: 202937
[No Abstract] [Full Text] [Related]
8. Managing patients who have myasthenia gravis.
Johns TR
West J Med; 1985 Jun; 142(6):810-3. PubMed ID: 4024633
[No Abstract] [Full Text] [Related]
9. The treatment of patients with myasthenia gravis.
Sanders DB; Scoppetta C
Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
[TBL] [Abstract][Full Text] [Related]
10. [Myasthenia gravis].
Takamori S
Naika; 1970 Jun; 25(6):1322-7. PubMed ID: 4914457
[No Abstract] [Full Text] [Related]
11. Management of myasthenia gravis.
Lancet; 1972 Apr; 1(7754):780-1. PubMed ID: 4111252
[No Abstract] [Full Text] [Related]
12. [Juvenile myasthenia gravis].
Ohno K; Sahashi K
Ryoikibetsu Shokogun Shirizu; 2001; (36):340-3. PubMed ID: 11596404
[No Abstract] [Full Text] [Related]
13. [Myasthenia gravis. Immunosuppressive treatment].
Horn J
Tidsskr Nor Laegeforen; 1971 Apr; 91(11):821-4. PubMed ID: 4326179
[No Abstract] [Full Text] [Related]
14. [Use of plasmapheresis in combined treatment of patients with severe form of generalized myasthenia].
Zaĭtsev VT; Krivoruchko IA; Klimova EM; Bondarenko TN; Florikian AK; Nechitaĭlo PE; Zhurov IuE; Shaposhnikov GA; Asanbaev AF
Klin Khir (1962); 1994; (4):33-5. PubMed ID: 7799584
[No Abstract] [Full Text] [Related]
15. Plasmapheresis: a new treatment modality for the patient with severe myasthenia gravis.
Eppel M; Streib EW
Nebr Med J; 1982 Apr; 67(4):72-4. PubMed ID: 7088214
[No Abstract] [Full Text] [Related]
16. [Myasthenia gravis. Treatment].
Somnier FE
Ugeskr Laeger; 1984 Jan; 146(5):345-8. PubMed ID: 6719608
[No Abstract] [Full Text] [Related]
17. [Treatment of myasthenia gravis].
Gajdos P
Presse Med; 1989 Oct; 18(35):1732-4. PubMed ID: 2531386
[No Abstract] [Full Text] [Related]
18. [Myasthenia gravis. Recent findings and their therapeutic consequences].
Thümler R; Haferkamp G
Dtsch Med Wochenschr; 1979 Oct; 104(40):1415-20. PubMed ID: 227650
[No Abstract] [Full Text] [Related]
19. Current treatment of myasthenia gravis.
Osterman PO
Prog Brain Res; 1990; 84():151-61. PubMed ID: 2267293
[No Abstract] [Full Text] [Related]
20. Ocular myasthenia gravis.
Gilbert ME; Savino PJ
Int Ophthalmol Clin; 2007; 47(4):93-103, ix. PubMed ID: 18049283
[No Abstract] [Full Text] [Related]
[Next] [New Search]